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D&&es. This study tested whether patients with vasospastic 
angina have impaired gkose tolerance or impaired insulin 
response. 
BaaRgnamd. Dyperinsoliiemio has been demonstrsted in pa- 
tients with coronary artery diise and syndrome X. 
il&#hdv. We perhnned tin ord glucose toleianee test (75 g) in 
30 patients with vasospastic angina in whom severe coronary 
vtisosposm wns induced by acetylcholine and in a matched group 
of3Opatientswithatypicalcbestpaininwhomnosignifkant 
vawpasm was imkzd. The responses of insolin and glneose 
were compnred betwee the two groups. No snbjects bad overt 
diabetes mellii, hyper&nsion, dyslipidemia, obesity or angio- 
graphically detwted signiit baselii coronary stenosis. Ve- 
nous blood samples were taken doring fasting and at 30,60,120 
aad 188 tnin after glucose load to obtain plasma glucose and 
lnnnm in!mlin level.% 
lfmolts. hpoired glncose tolerance was detected in the 19 
(63%) of 30 patients with vasospastic angina and in none of 
Epicardial coronary artery spasm is important in the patho- 
genesis of various forms of ischemic heart disease, including 
vasospastic angina, exertional angina and myocardial infarc- 
tion and often leads to sudden death (l-4). Coronary vase- 
spasm has been thought to correlate with the severity of 
atherosclerosis and endotheld dysfunction (5-9). An impaired 
release of endothelium-dcrked relaxing fac%r, a potent vaso- 
dilator, has been reported in atherosclerotic coronary arteries 
(S-9), sugesting the involvement of endothelial dysfunction in 
the pathogenesis of vasospastic angina. Acetylcholine dilates 
normal blood vessels by p?moting the release of endothelium- 
derived relaxing factor and produces vasoconstriction in ath- 
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30 patients with atypical chest pain (9 < 0.001). The immunore- 
active insulin levels at 60 and 120 min as well as tbe interval to 
peak insulin level were significantly greater in patients with 
vasospastic angina (p < 0.001). Among patients with vasospastic 
angina, those with acetylcboline4ndoced multivessel coronay 
vasospasm showed a significantly biier SW of iosolin concen- 
trations than those with single-vessel spasm (p < 0.01). During 
induction of coronary spasm, 10 patients with vasospastic angina 
presented ventricular arrhythmias. The snm of ioselin eoncentrn- 
tions was signiicantly greater in patients with than in tlmse 
without ventricnlnr arrhythmias. 
c0nelusin.v. Patients with vasospastic angina exhibited a bigb 
incidence of impaired glucose tolerance and delayed and signifi- 
cantly bier insulin responses. These tindings suggest that 
impaired glmwse tolerance with late hypersecretion of insulin may 
contribute to the pathogenesis of severe coronary vasospasm. 
(J Am CM Cudal 1996;27:1458-63) 
erosclerotic or diseased coronary arteries. This vasoconstric- 
tion occurs early in the angiographically normal coronary 
arteries as well as late in the course of coronary atherosclero- 
sis. Epicardial coronary arteries without angiographically sig 
nificant stenosis exhibit varying responses to acetylcholine, 
ranging from dilation or diffuse consktion to occlusive seg- 
mental spasm (10-14). The deterioration of endothelial func- 
tion has been attributed to several factors, including diabetes 
mellitus, dyslipidemia and hypertension. The endothelial dys- 
function observed in patients with diabetes mellitus, ,a potent 
stimulator of atherosclerosis, suggests a relatiodhip between 
coronary vasoconstriction in patients with vasospastic angina 
and the impaired gh~cose metabolism (15-17). 
Hyperinsulinemia, which has recently been demonstrated in 
patients with coronary artery disease and qndrome X, may 
also enhance coronary vasomotor tone in patients with vase- 
spastic angina (l&19). A possible link between acetylcholine- 
induced coronary vasoconstridion and hyperinsulinemia in 
patients with vasospastic angicla was recently proposed by 
Shimabukuro et al. (20). W. hypothesized that the patients 
with vasospastic angina in whom severe corqnary vasoconstric- 
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tion was induced may show not only hyperinsulinemia with 
normal plasma ghrcoz level but impaired gh~cose tolerance. 
This study was designed to determine whether impaired 
ghtcose tolerance or impaired insulin response to an oral 
glucose load are characteristic of patients with acetylcholine- 
induced total or subtotal severe coronary vasospasm. 
Methods 
Patients. This study included 30 Japanese patients with 
vasospastic angina (18 men and 12 women; mean age 53 years 
range 44 to 71) and 30 patients with atypir;t chest pain (18 
men and 12 women; mean age 54 years, range 45 to 70). A 
consecutive series of patients in Yokohama Minami Kyosai 
Hospital who fulfilled the entry criteria was prospectively 
included in the present study. Enrollment began in April 1993 
and was completed in May 1995. AU patients with vasospastic 
angina had a spontaneous episode of angina and coronary 
vasospasm, defined as total or subtotal (99% with delay) 
occlusion of the vessel associated with chest pain and/or 
myocardial ischemic ST segment changes on electrocardii- 
gram (ECG) after intracoronary injection of acetykholine 
(21). Thirty patients with atypical chest pain who showed no 
acetykhohne-induced significant coronary vasospasm (X0%) 
were selected to match to the patients with vasospastic angina 
for age, gender and body mass index. 
No significant coronary stenosis at baseline angiograms and 
no history of myocardial infarction, cardiomyopathy, conges- 
tive heart failure, peptic ulcer, chronic obstructive lung disease, 
renal disease, hepatic or endocrine disorders was noted in any 
of the 60 patients. All patients had normal ventricular function 
without segmental wag motion abnormality in the resting 
M-mode and on two-dimensional echocardiogram. Doppier 
echocardiograms revealed no abnormalities in any of the 
patients. NW of them received beta-adrenergic blocking 
drugs or other therapy that can atfeet plasma ghrcose and 
insulin sensitivity. Patients with overt diabetes mellitus, hyper- 
tension and hyperlipidemia were excluded from this study. 
Also excluded were subjects with a systolic blood pressure 
>140 mm Hg, a diastolic blood pressure >85 mm Hg, a total 
cholesterol >12.2 mmobliter (220 m&d!), a triglyceride 
X3.3 mmohliter (150 mgidij, a high-density lipoprotein cho- 
lesterol <2.2 mmol/liter (40 mgldl) or a body mass index 
>25 kg/m*. Total cboksterol, triglyceride and high-density 
lipoprotein cholesterol were measured using protein standard 
etuynztic methods Patients with a fasting plasma ghtcose 
kvel>6.7 mmoi/liter (120 mgldl) and a causal piasma glucose 
>ll.l mmohliter (200 mgldl) were excluded. These data were 
obtained during the fasting state 3 days after cardiac catheter- 
ization. Table 1 shows the clinical characteristics of each group. 
No significant difference between the two groups was observed 
for any of variables (Table 1). Tire study protocol was approved 
by the ethics committee at our institution, and all patients gave 
theii writ& hformed consent to pa&ipate in the study. 
Ghtense toti teat. Ghmse tokrance test was per- 
formedineachpatient3daysaftercardiacca&te&ationAll 
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Table 1. Patient Characteristics 
Age w 
Gender (M/F) 
Fkdy mass index (kgm’) 
Total cholesterol (mmoliliter) 
WA (‘) VSA (-) 
Group GrOUp 
(n = 30) (n = 30) 
5s r:! 54-2 
WI? 18’12 
22.2 z 0.4 22.4 -c 0.4 
:0.7 + 0.3 10.6 r 0.4 
Trigtywides (mmolditer) 6.X ? 0.3 6.4 2 0.2 
HDLC (mm&liter) 2.8 2 0.2 2.8 r 0.1 
Systolic BP :mm HE) 126?3 122t3 
Diastolic BP (mm Hg) 812 I 7921 
Smoking (yesino) ltY?u 9’21 
Values are eqessed .B mean +_ SEM 01 number of patient. BP = blood 
p-e: F = female; HDLC = hi-density lipoprotein cboles:erol: M = maie; 
VSA (t) Group = patients with vasqwtic angina; VSA (-) Group = patients 
WifIt atypial chest pain. 
60 patients followed their normal diet and restricted perfor- 
mance of heavy physical exercise, smoking and caffeine for 3 
days before the test, After an overnight fast, patients received 
oral administration of a glucose sohrtion (75 g in 200 ml of 
water) at 8 a.m. Venous blood samples were taken during 
fasting and at 30,60,120 and 180 min after the ghiccse load. 
The sum of plasma ghrcose (mmokliter) and the sum of 
immunoreactive insulin responses (pU/ml) to the ghtcose load 
were calculated. plasma was stored at -WC, and each sample 
was assayed for ghtcose and immunoreactive insulin. Plasma 
ghrcose was determined with an autoanalyzer using a glucose 
oxidase method. Immunoreactive insulin levels were assessed 
by radioiiunoassay method using an antihuman instrIm, 
antibody. 
Angiogmpbic anal@. The Judkins technique was used to 
perform coronary arteriography in the morning while patients 
were fasting and not sedated. Ag antianghuu drugs except for 
sublingual nitmglycerin were discontinued at least 3 days 
before the study. Basebue coronary arter&aphy of the kti 
cmonary artery in the right anterior oblique prc+ctiin and of 
the right coronary artery in the left anterior oblique piojectkm 
was performed. A bipolar ekctrode catheter was inserted into 
the right ventricular apex via the right femoral vein and, 
cmmected to a temporary pacemaker. The pacing rate was set 
at 50 beats/mm. Incremental doses of acetykhoiine were 
i+cted into the heft coronary artery (20,50 and ltkl ~9) and 
the right ammary artery (20. SO and 70 pg) until acetykhohne- 
induced total or subtotal v-ion was detected angio 
gmphka@ or until the maximum dose was given. Finally, 
arteriograms were obtained in several pmjectii after the 
injection of 1.0 mg of isosorbide dir&rate into the left and right 
coronary arteries, and the organic cororq artery lesion was 
evaluated. During the study, two leads of ECG (11 and Vs or 
V,) and arterial blood pressure were continuously monitored. 
Standard 12&d ECGs were recorded at appropriate intervals 
using radidilcent carbon eWrode (21). 
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Table 2. Resuks of Glucose Tolerance Testing (mean t SEM) 
WA (+) Group VSA (- ) Gmup 
Test h = 30) (n = 30) p Value’ 
PG (mmoi/liter) 
Fastiag 5.3 z 0.1 4.9 ? 0.1 NS 
30min 9.4 + 0.3 1.6 2 0.3 < 0.001 
6Omin 9.9 i- 0.5 6.1 2 0.3 c 0.001 
120 min 1.6 2 0.4 5.5 c 0.2 < 0.001 
l&l min 4.8 ST 0.3 4.4 c 0.3 NS 
Total PG 37% 1.3 3” 1.1 < O.ol)l 
IRI luU/mll ~~.. I 
Ftiillg 9.2 z 1.2 6.8 2 0.9 NS 
3Omin 43.0 2 4.5 42.3 ; 4.9 NS 
60 min 66.7 2 8.5 28.1 + 2.9 < 0.001 
120 min 62.2 + 10.1 22.9 + 3.1 < 0.001 
180 mitt 28.3 2 4.3 15.4 2 4.2 NS 
Total IRI 7s 2 24 123t19 < 0.001 
*Patients with atypical chest pain [VSA (-) Group] versus patients with 
vasqwtk angina [VSA (+) Group]. IRI = immunoreactive insulin concentra- 
tions: PG = dasma glucose; Total IRI = sum of immunoreactive insulin . - 
coneentratiom; Total PG = sum of plmma glucose levels 
variables. Fisher exact probability test or chi-square test was 
used to evalmte Differences in categorical variables between 
the two groups. A p value c 0.05 was considered to indicate 
statistical significance. 
The sample size of the two groups was determined to give 
a power of 80% to detect a 30% difference in the sum of msulin 
concentrations between the patients with vasospastic angina 
and those with atypical chest pain. This calculation assumes 
that the sum of insulin concentrations in the patients with 
atypical chest pain is 120 t 70 pU/ml, as seen in the normal 
subjects in previous studies from our laboratory in which an 
oral glucose tolerance test was performed using the same 
protocol as in this study. Assumptions in this calculation 
include equal variances and SD in the two groups. 
Results 
Glucnse and insniii responses durfng ghtcose tolerance 
test Table 2 shows the glucose and insulin responses in both 
groups Impaired glucose tolerance was detected in 19 (63%) 
of 30 patients with vasospastic angina, and diabetes mellitus 
was documented in 3 patients (10%) based on WHO diagnos- 
tic guidefines (22). None G: :he patients with Aypical chest 
pain showed either impaired ghtcose tolerance or diabetes 
mellitus. The diierence in the incidence of impaired glucose 
tolrxance between the two groups was statistically sigaificant 
(p < 0.001). The plasma ghtcose levels during fasting and at 
180 min after oral glucose load were within the normal range 
in all 60 patients. The plasma glucose levels at 30, 60 and 
120 mhr and the sum of plasma ghtcose concentrations were 
signitkantly higher in the patients with vasospastic angina than 
in those with atypical chest pain (Table 2). 
There was no sigdhnt di&raiee between the hvo groups 
in the plasma immunoreacti~ btsuhn concentrations durhtg 
JACC Vol. 27. No. 6 
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fasting or at 30 and 180 min after glucose load. However, the 
immunoreactive insulin level at 60 and 120 min and the sum of 
immunoreactive insulin concentrations were significantly 
higher in the patients with vasospastic angina than those with 
atypical chest pain (p < 0.001). The interval from glucose load 
to the peak ,insulin level was greater in the patients with 
vasospastic angina (Table 2). These data revealed impaired 
glucose tolerance and late i:ypersecretion of insulin during the 
oral glucose tolerance test r., patients with vasospastic angina 
despite comparable baseline insulin concentrations and glu- 
cose leveis in the two groups. 
Angiographic results. None of the patients with atypical 
chest pain showed significant vasospasm (>50%) or ischemic 
ST segment changes either at baseline or after the incremental 
intracoronary injection of acetylcholine. The total coronary 
vasomotor response (percent lumen diameter decrease) to 
acetylcholine ranged from -10% to 50% (31.3 2 3.0%) in 
patients with atypical chest pain. In the patients with vasospas- 
tic angina, no chest pain or myocardial ischemic ECG changes 
were observed at baseline before acetylcholine injection. .It 
baseline, two patients had spontaneous 25% vasospasm of the 
right coronary artery, and hvo patients had 25% vasospasm of 
the left anterior descending artery. One patient experienced 
50% vasospasm of the right coronary artery but did not exhibit 
ischemic ECG changes or chest pain. The remaining 25 
patients had normal coronary arteries at baseline coronary 
angiography. 
Among the 30 patients with vasospastic angina, the sequen- 
tial intracoronary injection of acetylcholine into the right and 
left coronary arteries produced a total occlusion of at least one 
coronary artery in 27 cases and a subtotal occlusion of at least 
one coronary artery in 3 cases. Total occlusion was induced in 
36 vessels of 27 patients, and subtotal occlusion was induced in 
19 vessels of 17 patients. Vasospasm of multivessel coronary 
arteries was induced in 18 of the 30 patients with vasospastic 
angina, and vasospasm of a single coronary artery occurred in 
the remaining 12 patients. The sum of insulin concentrations 
during oral glucose tolerance test was signficantly greater in 
the 18 patients with multivessel vasoconstriction than in the 12 
patients with single-vessel coronaty vasospasm (254 2 35 vs. 
142 2 22 cclJ/ml; p i 0.01) (Fig. 1). There was no significant 
difference between these two groups in terms of age, body mass 
index, serum lipid concentrations, blood pressure or smoking 
habits. During the induction of coronary spasm by the acetyl- 
choline injection, 10 patients with vasospastic angina exhibited 
ventricular arrhythmias, while 20 patients did not. The sum of 
insulin concentrations during oral glucose tolerance test was 
significantly greater in these 10 patients with ventricular ar- 
rhythmias than in those without ventricular arrhythmias 
(308 2 49 vs. 160 2 19 &/ml; p < 0.01) (Fig. 2). Further, 
when 8 patients in whom muttivessel vasospasm accompanying 
ventricular arrhythmias was induced were compared with the 
remaining 22 patients, the sum of insulin concentrations during 
oral glucose tolerance test was significantly greater ti these 8 
patients (320 t 57 vs, 169 2 20 ~;U/rt& p < 0.01). AU patients 
with vasospastic angina showed typical ischemic symptoms 
JACC Vol. ?i. No. 6 
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(n=l2) (n=lE) 
Fire 1. fmmunoreactive insulin concentrations in response to oral 
glucose load in patients with single-vessel spasm (n = 12) and 
multivessel spasm (n = 18). Bars indicate SEM, and open circles 
indicate mean values. Total IRI = sum of immunoreactive insulin 
concentrations. Single-vessel group (n = 12) includes patients with 
constriction of a single vessel in response IO acetykholine injection. 
Multivessel group (n = 18) includes patients with constriction of 
multiple vessels in response to aeetylcholine injection. p < 0.01, 
single-vessel group versus multivessel group. 
during the induction of coronary spasm bv the acetvlchoiine _ _ 
injection. Thus, all 30 patients with vasospastic angiia in our 
study developed severe vasomnstriction and typical ischemic 
symptoms in response to acetylcholine injection. 
All patients with vasospastic angina exhibited normal cor- 
onary arteries without observation of organic stenosis after the 
administration of isosorbide dinitrate. The acetylcholine- 
induced symptoms and ECG changes were completely relieved 
by the injection of isosorbide dinitrate. There was no major 
complications relating to the injection of acetylcholise either 
in the catheter laboratory or after the catheterization. 
Discussion 
This appears to be the first study to demonstrate a high 
incidence of impaired glucose tolerance to an oral glucose load 
in patients with vasospastic angina who exhiitro axtykholine- 
induced total or subtotal coronary vasoconstriction. A pattern 
of delayed insulin secretion and a significantly higher insulin 
response during a glucose tolerance test were detected in these 
patients without overt diabetes mellitus, hypertension, hypex- 
lipidemia or obesity. 
C0rumuyvasospasmandimpairedglwwetolerancc The 
extent of atherosclerosis determines the degree of coronary 
vamspasm, as evidenced by the similarity between the predii- 
tars for vasospastic angina or afetykholine-induced vasomn- 
striction and coronary risk factors for athemselerosis (5-14). 
Yasue et al. (12) evaluated the response of human coronary 
arteries to the intracoronary injection of acetykzholine and 
suggested that all cornnary arteries in patients with vasoq&f 
angina are affe&d by endothelii dy&nc&m or a&ems&- 
~e~~~~~~~~rn~~~ 
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v-m*) Va*ic9rrrllhna.) 
h=f~ m=m 
Fii 2. Immunoreactive insulin concentrations in response to oral 
glucose load in patients with and without ventricular arrhythmias. 
Total IR1 = sum of immunoreactive insulin concentrations; Ventric- 
ular arrhythmia (+) (n = 10) = patients with ventricular arrhythmia 
during the induction of coronary spawn hy the acetykholii injectii; 
Ventricular arrhythmia (-) (n = 3) = patients without ventricular 
arrhythmia during the induction of coronary spasn by the acetykh~ 
line injection. Results shown arc mean value &&d edsstac) and SEM 
(bsrs). 
graphically normal. Impaired release of endotheliumderived 
relaxing factor as a result of endotbelial dysfunction has been 
reported in atherosclerotic coronary arteries, suggesting that 
atherosclerosis-induced endothelii dysfunction may also be 
important in the pathogenesis of coronary vamspasm (23.24). 
However, Yamamoto et al. (25) and Egashira et al. (26) 
recently reported that endotbeliumdependert vasodilation is 
preserved in vasospastic sites in patients with va.uqstic 
angina, which suggests that coronary vasqx~~ maYbepro- 
voked mainly by a supersensitivity of the vascuhu smooth 
muscle cells. An increase in the contractility or hyperre&vity 
of the vascular smooth muscle may be associated with various 
stimuli such as dy&pidemia, obesity, hypertension, glucose 
intolerance, and hyperinsubnemia. Among these factors. hy- 
perinsulinemia may he an importaM candidate that attenuates 
the vascular tone of patients with vasospa& angina. The 
insulin resistance syndrome reportedly contriites to atbem- 
genesis in the presence of such risk factors as ~~JCQS intoler- 
ance, dyslipidemia, obesity and ~rtension (B-17,20). In 
vitro studies by Heistad et al. (27) demonstrated that insulin 
exe* a direct hypertrophic effect on the vascular endothelium 
and the smooth mi&e cells, which suggests a possiMe in- 
volvement of hyperinsulinemia in the pathogenesis of vaso- 
spastic angina. Shimabukuro et al. (20) recently showed that 
acetykholine-induced coronary vasoconMction in pa&n& 
with vasoqmstic angina is correlated with hyperins&emia 
and an enhanced insulin respome. IO their study, patients with 
vasqastic angina showed only modest vasoconstrictii 
(-185 2 9.5% in diameter, !xvere vasoconstri&m was 
observedinonly3vessels)inresponxtotheintmmmmuy 
itljebnof and?Tjm@msrelatedtotheia- 
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duccd va~~~pa~m were not reported. Ir contrast, the patients 
with vasospdc angina in our study showed total or subtotal 
coronary wrqrasm and experienced the typical chest pain 
after the acetykbolme injection. Further, our study population 
was abut twice as large as theirs. Such diierenccs may explain 
the significantty high incidence of impaired glucose tolerance 
observed in our patients with vasospastic angina. We also 
&wed, not like in their study, that there was no signiticant 
difference in serum triglyceride level between patients with 
maospa& augina and those with atypical cheat pain. Because 
abnormal lipid metabolism per se can lead to acctylcholine- 
induced vasoconstriction, the present study indicates the pres- 
ence of a high incidence of impaired glucose tolerance or a late 
bypersecretion of instdin in patients with vasospastic angina, 
independent of dysbpidemia. 
Impaired giucose tolerance is a category that permits 
dami6cation of an individual whose ghtcose tolerance is above 
the convemional normal range but lower than tbe level con- 
sidered diagnostic of diibetes mellitus (2%). Such subjects have 
a b&Jr risk of developins diabetes mellitus and appear to have 
a greater I& for coronary artery disease than those of similar 
age with normal gbrcose tobxance (28). Possible mechanisms 
for endotbelial dysfimction in patients with diabetes mellitus 
have been proposed to explain abnormal endothelium- 
dependent relaxation (29-32). These include abnormalities in 
sigual tmn&ct& reduced synthesis of endotheliumderived 
relaxing factor, accelerated mactivation of nitric oxide. and 
generation and release of competing vasoconstrictor sub- 
strmces (29-32). We speculate tbat impaired ghtcose toierance 
itself may a&x% coronary artery vasomotor tone and accelerate 
the endotheIid dyshction in patients with vasoqxtic angina. 
Vaauspa&c au&m aud sudden de&. Curr et al. (33) 
recently suggested tbat diabetes mellitus and impaired gbmose 
tolerance are importam predictors for long-term risk of sudden 
death, sqpsthg an infmasd susqtiiity to fatal ventricrdar 
drrhybb in the subjects, at least in part from coronary 
%%smpam (34-39). Fatal ventricular arrbytbmias have been 
documented frequently in patients witb vasoqu&ic angina and 
are asmdated with an increased incidence of cardiac events, 
it&ding sudden death (40-42). In tbe present study, 10 of 30 
patients witb vasospastic angina experienced ventricular ar- 
rhythm& and tbe sum of insubn concentrations during the 
gbrcose tolerance test was sigailicantly greater in these patients 
than in those without ventricular mrhytbmias. A sigaiticrmt 
ditbxence in tbe sum of insulin coucentrations was also 
ohserved between patients with mubivemel vasoconstriction 
and those with single-vessel vasocons tliction. These fmdings 
suggest tbat tbe susqtiiity to sudden death in tbe patients 
witb diabetes meliitus aad impahed gbrcose tolerance reported 
in study by Cm% et al. (33) may be related to tbe combmed risk 
of imp&ml gbrcose memboiism and accompanying severe 
-~- 
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insulin resistance in the patbogenesis of coronary vasospasm is 
still unclear. We attribute the occurrence of vasoconstriction to 
a locabid disorder as well as increased basal tone a&ted by 
various stimuli. An impaired gbtcpse tolerance with late byper- 
secretion of insulin during oral glucose tolerance test may play 
an important role in delcloping an increased vessel tone 
susceptible to severe vasoconstriction in patients with vase- 
spastic angina. 
We thank Takawki Watanabe. MD. for comments on the manuscript. 
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